56 studies found for:    Open Studies | "Keratosis, Actinic"
Show Display Options
Rank Status Study
21 Recruiting Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest Including 12-month Follow-up
Condition: Actinic Keratosis
Interventions: Drug: LEO 43204 gel;   Drug: Vehicle gel
22 Recruiting A Ph2a, Open-Label, Multicenter, Activity&Safety Study of KX2-391 Oint in Subj. w Actinic Keratosis on the Face or Scalp
Condition: Actinic Keratosis
Intervention: Drug: KX2-391
23 Recruiting Clinical Trial of Ingenol Mebutate Gel 0.015% & 0.05% in Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: ingenol mebutate gel 0.015%;   Drug: ingenol mebutate gel 0.05%
24 Recruiting Ingenol Mebutate Gel 0.05% in Kidney Transplant Recipients With Actinic Keratoses
Condition: Actinic Keratosis
Intervention: Drug: ingenol mebutate 500 ucg
25 Not yet recruiting Efficacy and Safety of VDA-1102 Ointment in the Treatment of Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: Placebo;   Drug: 5% VDA-1102;   Drug: 10% VDA-1102
26 Not yet recruiting A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors
Conditions: Keratosis, Actinic;   Keratosis;   Skin Neoplasms
Interventions: Drug: Heliocare with Fernblock PLE technology;   Other: Sugar Pill
27 Recruiting Fractional Laser-assisted Daylight Photodynamic Therapy Versus Daylight Photodynamic for Treatment of Actinic Keratoses
Condition: Actinic Keratosis
Interventions: Procedure: Pretreatment with CO2 laser before photodynamic therapy;   Device: Only photodynamic therapy
28 Recruiting Bilateral Comparison of Treatment of Facial Actinic Keratoses Using Microneedling and Photodynamic Therapy With Aminolevulinic Acid and Blue Light Versus Photodynamic Therapy With Aminolevulinic Acid and Blue Light Using Two Incubation Times
Condition: Actinic Keratoses
Interventions: Drug: Aminolevulinic Acid (ALA);   Device: Environ Cosmetic Roller;   Device: BLU-U IIlluminator
29 Recruiting Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)
Condition: Keratosis, Actinic
Interventions: Drug: Aminolevulinic Acid (ALA);   Device: BLU-U
30 Not yet recruiting Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients
Condition: Actinic Keratosis
Intervention: Drug: ingenol mebutate gel 0.015%
31 Recruiting Microneedle Lesion Preparation Prior to ALA-PDT for AK on Face
Condition: Actinic Keratosis
Interventions: Drug: ALA;   Drug: Topical Solution Vehicle;   Device: IBL 10 mW;   Procedure: Microneedle lesion preparation;   Device: IBL 20 mW
32 Recruiting The Use of Microneedles to Expedite Treatment Time in Photodynamic Therapy
Condition: Keratosis, Actinic
Interventions: Device: Microneedle Roller;   Drug: Aminolevulinic Acid;   Radiation: Blue Light
33 Recruiting An Open-Label Safety Study of A-101 Solution
Condition: Seborrheic Keratosis
Intervention: Drug: A-101 Solution
34 Recruiting Daylight-PDT With MAL for AK and Photodamaged Skin
Conditions: Actinic Keratoses;   Photodamaged Skin
Interventions: Drug: Daylight photodynamic therapy using Methylaminolevulinate (MAL);   Procedure: Cryosurgery
35 Recruiting Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%
Condition: Actinic Keratosis (AK)
Interventions: Drug: Ingenol Mebutate Gel, 0.015%;   Drug: Imiquimod Cream, 5%
36 Recruiting Tobacco Cessation Intervention Study for Oral Diseases
Conditions: Smoking Cessation;   Mouth Diseases;   Periodontal Diseases;   Leukoplakia;   Lichen Planus;   Keratosis;   Implant
Intervention: Other: Tobacco cessation intervention
37 Recruiting A Clinical Trial Evaluating the Role of Systemic Antihistamine Therapy in the Reduction of Adverse Effects Associated With Topical 5-aminolevulinic Acid Photodynamic Therapy
Condition: Actinic Keratoses
Interventions: Drug: Antihistamine Cetirizine Hydrochloride;   Other: Placebo
38 Recruiting PMS to Evaluate the Safety and Efficacy of Picato® Gel
Condition: Actinic Keratosis
Intervention: Drug: Ingenol mebutate 0.015 percent or 0.05 percent gel
39 Not yet recruiting Treatment of Field Cancerization for Reduction in Tumor Burden - A Prospective Study
Conditions: Extensive Photodamage;   Actinic Keratosis;   History of Numerous Skin Cancers
Interventions: Device: Ultrapulse Carbon Dioxide Laser;   Device: Cellutome epidermal harvesting system
40 Unknown  5fluorouracil for Advanced Photoaging
Conditions: Photoaging;   Actinic Keratosis
Interventions: Drug: 5-fluoruracil;   Procedure: 5-fluoruracil

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-56) Show next page of results    Last Page
Indicates status has not been verified in more than two years